We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2670:TSEABC-MART, INC. Analysis

Data as of 2026-07-27 - not real-time

HK$159.50

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Beijing Yunji Technology’s share price sits at HK$159.5, well below its 20‑day SMA of 188.6 and the 200‑day SMA of 187.3, signaling a bearish backdrop despite a recent bullish MACD crossover (MACD line -30.2 above signal -32.2) and a modest positive histogram. The 14‑day RSI of 34.7 places the stock in oversold territory, while volume is on a decreasing trend and 30‑day volatility spikes above 120%, suggesting heightened price swings. A beta of 0.63 points to lower systematic risk, yet the Fear & Greed Index at 88.09 marks “Extreme Greed,” implying that market sentiment may be overly optimistic.
Fundamentally, the company posted a 28.5% revenue surge but suffers from severe profitability issues, with operating and net margins near –82% and –98% respectively, and negative free cash flow exceeding HK$1.9 billion. Valuation metrics are extreme: a forward P/E of 918×, price‑to‑book of 11.2×, and price‑to‑sales of 36.7× contrast sharply with an industry P/E average of 31.4×, while the consensus target price of HK$148.7 implies a downside of about 7%. The balance sheet appears solid with minimal debt (debt‑to‑equity 0.04) and ample cash (HK$773 million), but operating cash flow remains negative, and no dividend is offered.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Oversold RSI indicating potential further price decline
  • Current price above target price and high valuation multiples
  • Decreasing volume and extreme volatility increasing downside risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth offering upside if margins improve
  • Continued cash burn and negative operating cash flow
  • Support level near HK$134 providing a floor for price action

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Potential market leadership in commercial service robots in China
  • Low debt and substantial cash cushion to fund restructuring
  • Long‑term secular demand for automation across hospitality, retail, and healthcare

Key Metrics & Analysis

Financial Health

Revenue Growth28.50%
Profit Margin-97.89%
P/E Ratio918.2
ROA-15.61%
Debt/Equity0.04
P/B Ratio11.2
Op. Cash FlowHK$-169818000
Free Cash FlowHK$-1975962496
Industry P/E31.4

Technical Analysis

TrendNeutral
RSI34.7
SupportHK$134.00
ResistanceHK$327.80
MA 20HK$188.56
MA 50HK$260.78
MA 200HK$187.27
MACDBullish
VolumeDecreasing
Fear & Greed Index88.09

Valuation

Target PriceHK$148.67
Upside/Downside-6.79%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.63
Volatility124.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.